US FDA clarifies regulatory authority for human dura mater
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration has amended its device regulations to clarify that all human dura mater recovered after 25 May 2005 is subject to a rule governing human cell, tissue, and cellular and tissue-based products (HCT/Ps) rather than to medical device regulations1.